Sino Biopharmaceutical profit falls by 16pc to 1.2b yuan

Sino Biopharmaceutical (1177) recorded a net profit of 1.21 billion yuan (HK$1.37 billion) for the first half, down by  16 percent from a year ago.

The drugmaker declared a quarterly dividend of 2 HK cents for the second quarter this year, totaling  4 HK cents dividend for the first six months.

The basic earnings per share were 9.64 fen, down by  16 percent year-on-year.

Excluding the impact from the acquisition of 24 percent interest in Beijing Tide and other fair value changes, underlying profit grew by 5.2 percent, from a year ago to 1.76 billion yuan.

Total revenue increased by 1 percent to 12.65 billion yuan.

Shares gained by  1.54 percent to HK$9.24 today.